Alvogen to Acquire Product Portfolio from Pfizer for the U.S. Market, no terms

By: via Benzinga
Alvogen has entered into a definitive agreement with Pfizer Inc. (NYSE: PFE), under which it will acquire a portfolio of four ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.